Skip to main content
. 2024 Oct 13;23:3692–3701. doi: 10.1016/j.csbj.2024.10.013

Fig. 3.

Fig. 3

This case study uses HerpDock to reveal which drugs would inhibit gD interaction with HVEM or Nectin1: (A) Flow chart giving an overview of the case study (B) Top 4 cancer drugs that can inhibit gD interaction with HVEM and Nectin-1 (C) Top 4 non-cancer drugs that can inhibit gD interaction with HVEM and Nectin-1 (D) Visualization of top hit Rilapladib’s interaction with gD at it’s HVEM binding site (E) Visualization of top hit Rilapladib’s interaction with gD at it’s Nectin1 binding site.